Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Harsha Sugur"'
Publikováno v:
Neuropathology.
Autor:
Palavalasa Sravya, Vidya Nimbalkar, Brijesh Kumar Verma, Banavathy S Kruthika, Vani Santosh, Arimappamagan Arivazhagan, Paturu Kondaiah, Yasha T Chickabasaviah, Shilpa Rao, Harsha Sugur
Publikováno v:
Journal of Neuro-Oncology. 152:55-65
Glioblastoma (GBM) is a highly invasive tumor. Despite advances in treatment modalities, tumor recurrence is common, seen mainly in the peritumoral brain zone (PBZ). We aimed to molecularly characterize PBZ, to understand the pathobiology of tumor re
Autor:
Vidya Nimbalkar, AS Uday Krishna, Sampath Somanna, Palavalasa Sravya, Vani Santosh, Shilpa Rao, Paturu Kondaiah, Nandaki Kanuri, Brijesh Kumar Verma, Arimappamagan Arivazhagan, Harsha Sugur, Paramita Kundu
Publikováno v:
Mitochondrion. 55:154-163
Introduction Mitochondrial DNA (mtDNA) content in several solid tumors was found to be lower than in their normal counterparts. However, there is paucity of literature on the clinical significance of mtDNA content in glioblastoma and its effect on tr
Publikováno v:
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 38(9)
Astroblastomas are central nervous system tumours with unknown cell of origin and clinical behaviour. These tumours occur most commonly in cerebral hemispheres with spinal astroblastomas being very rare. We report a case of spinal astroblastoma which
Autor:
A R Prabhuraj, Somanna Sampath, A Arivazhagan, Alok Mohan Uppar, B Indira Devi, Harsha Sugur, Vani Santosh, M Bhaskara Rao
Publikováno v:
Child's Nervous System. 35:1537-1545
Pediatric glioblastoma (pGBM) tumors have been identified as an entity distinct and different from the adult variety of GBM not only with respect to pathogenesis, genetics, and molecular alterations but also in clinical outcomes and overall survival.
Autor:
Vani Santosh, Jitender Saini, Yasha T Chickabasaviah, Radhika Mhatre, B N Nandeesh, Harsha Sugur
Publikováno v:
Brain Tumor Pathology. 36:112-120
Astroblastomas are unique tumours with unresolved issues in terms of their origin, molecular biology, clinical behaviour, and response to treatment. To decipher the characteristics of this tumour, we reviewed cases histologically diagnosed as astrobl
Autor:
Vani Santosh, Janhvi Jaiswal, H R Arvinda, Sampath Somanna, Arimappamagan Arivazhagan, Vinayak Narayan, Harsha Sugur
Publikováno v:
Pediatric Neurosurgery. 54:329-340
Objective: Medulloblastoma (MB) is a heterogenous tumor, and the prognosis is influenced by various clinical, histological, and molecular factors. The aim of the study is to determine the clinical profile and radiologic characteristics among the hist
Autor:
S D Shwetha, Paritosh Pandey, Vani Santosh, Arimappamagan Arivazhagan, K S Rajmohan, Harsha Sugur
Publikováno v:
Neurology India. 68(4)
The WHO 2016 classification of diffuse gliomas has incorporated molecular markers isocitrate dehydrogenase (IDH) gene mutations (IDHmut) and codeletion of chromosomal arms 1p and 19q (1p/19q codeletion) as tumor defining entities. The diagnosis of di
Autor:
B Ravi Mohan Rao, B N Nandeesh, Santosh Kumar Annayappa, Saikat Mitra, T C Yasha, Shilpa Rao, Vani Santosh, Harsha Sugur, Vikas Vazhayil
Publikováno v:
Brain tumor pathology. 38(1)
Central nervous system high grade neuroepithelial tumor - BCOR altered is a newly defined entity which is characterised by internal tandem duplication (ITD) in exon 15 of BCOR. These tumors resemble high grade glioma histologically and exhibit BCOR i
Autor:
Sampath Somanna, Vani Santosh, Janhvi Jaiswal, Shilpa Rao, Aditi Chatterjee, Harsha Gowda, Vinayak Narayan, A Arivazhagan, S D Shwetha, Harsha Sugur
Publikováno v:
Clinical neurology and neurosurgery. 196
Objectives The objective of the study was to identify novel medulloblastoma (MB) biomarkers through proteomic profiling, correlate it with the molecular subgroups of MB and assess the clinical significance. Methods Archived paraffin embedded tumor ti